DJIA 17,051.73 -48.45 -0.28%
NASDAQ 4,424.70 -7.44 -0.17%
S&P 500 1,973.63 -4.59 -0.23%
market minute promo

303.73 -2.19 (-0.72%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

REGN $303.73 -0.72%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $306.20
Previous Close $305.92
Daily Range $302.46 - $307.79
52-Week Range $227.64 - $352.49
Market Cap $30.6B
P/E Ratio 87.66
Dividend (Yield) $0.00 (0.0%)
Volume 562,231
Average Daily Volume 975,278
Current FY EPS $9.29

Sector

Healthcare

Industry

Drugs

Regeneron Pharmaceuticals, Inc. (REGN) Description

The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions. Website: http://www.regeneron.com/

News & Commentary

Cholesterol-Lowering Drug Market Heats Up

This video discusses Amgen's evolocumab, Rengeneron Pharmaceuticals and Sanofi's alirocumab, and the rest of the PCSK9 inhibitors.

3 Stocks Reiterated As A Hold: NTAP, FSLR, REGN

InsiderInsights.com Daily Round Up: 7/17/14

Analyst Issues Top Biotech Stocks to Buy Ahead of Earnings

Sector Update: Health Care Shares Mixed Pre-Market

Sector Update: Health Care

Notable Two Hundred Day Moving Average Cross - REGN

Biotech Stock Roundup: AbbVie Woos Shire with Revised Offer, Sarepta Slips on Eteplirsen Data - Anal

Biotech Stock Roundup: AbbVie Woos Shire with Revised Offer, Sarepta Slips on Eteplirsen Data - Analyst Blog

SHPG, REGN And LLY, 3 Drugs Stocks Pushing The Industry Lower

Some Elegant Biotech Platforms I Read About While Looking For The Next Regeneron

InsiderInsights.com Daily Round Up: 7/14/14

See More REGN News...

REGN's Top Competitors

REGN $303.73 (-0.72%)
Current stock: REGN
AMGN $119.03 (0.62%)
Current stock: AMGN
GILD $88.86 (-0.37%)
Current stock: GILD
BIIB $302.50 (-0.53%)
Current stock: BIIB